NCT02584725View on ClinicalTrials.gov

Tranexamic Acid Dosing for Total Joint Arthroplasty

PHASE4CompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions
Arthropathy of HipArthropathy of Knee
Interventions
DRUG

Tranexamic Acid

Comparison of 3 different doses of the drug

All Listed Sponsors
lead

Columbia University

OTHER

NCT02584725 - Tranexamic Acid Dosing for Total Joint Arthroplasty | Biotech Hunter | Biotech Hunter